ReviewFrontiers in endocrinology2023

Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors.

Jacob E Pruett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.